glp 1 and addiction GLP-1 medications are getting attention for their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch Five things to know about

Improves pigmentation of the skin such as melasma, scars, improper chemical peel and post chicken pox

The author or authors do not own shares in any securities mentioned in this article

Retrieved 24 October 2023

Given that obesity is a chronic and relapsing disease, it is important to understand the effectiveness of different strategies to maintain WL: TRIUMPH-6 (NCT06859268) will assess changes in bodyweight at 116 weeks in individuals with obesity who have completed 80 weeks of retatrutide, comparing continued treatment at high or low doses of retatrutide versus switching to placebo for the last 36 weeks

Faisal Z, Mazhar A, Batool SA, Akram N, Hassan M, Khan MU, Afzaal M, Hassan UU, Shah YA, Desta DT